Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Privacy Policy  
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english espańol polski francais
Home / WELCOME / Archiv / Equine /     
 
New test determines exposure to strangles in horses
2637_horse_small.jpg Picture: Ā© Bayer Animal Health
A new ELISA test to determine a horse`s level of exposure to strangles is under development at Colorado State University`s (CSU) veterinary teaching hospital. It would give veterinarians a tool to efficiently assess the horse`s risk level by evaluating the animal`s blood antibody titers.

Strangles is a highly infectious disease in horses that affects the upper respiratory tract and the lymph nodes surrounding the throat, causing swelling and abscessation.

`What we hope to achieve with this test is the ability to definitively determine a horse`s risk level so that the owner can more quickly make informed health-related management decisions,` explains Dr. Ann Davidson, one of the equine veterinarians creating the test.

The basis of this ELISA method, developed specifically for Streptococcus equi, relies on whether there are antibodies to the bacteria in the blood. If an animal has been exposed, the test would detect those antibodies and would reflect a high titer.

`One of the challenges in diagnosing strangles lies with horses that are not exhibiting signs of active illness, but are carriers shedding the bacteria. It is often through contact with these shedders that other horses can become infected.`

Currently, tests exist only for horses with active signs of disease. The `gold standard` is a laboratory culture of the nasal discharge or abscess material. Another method is a polymerase chain reaction test, or PCR test.

`The advantage to the ELISA test on the horse`s serum is that we can now determine those horses who may not have been exposed and are at risk,` says Dr. Josie Traub-Dargatz of CSU, another of the test`s researchers.

`Once perfected, we hope the test results will be rapid and readily available, making it a very useful tool for equine veterinarians.`


Source: www.dvmnewsmagazine.com
Foto: http://www.nrce.nic.in/photos/strangles.jpg
Indian Council of Agricultural Research



Tell a friend   |   Print version   |   Send this article

EQUINE

Valacyclovir in horses with equine multinodular pulmonary fibrosismembers
Equine herpesvirusā€5 is commonly isolated from the lungs of horses with EMPF, suggesting an etiological link. Valacyclovir is used empirically to treat EMPF; however, no data is available concerning its impact on EHVā€5 viral kinetics. The objectives of this study were to determine the effect of oral administration of valacyclovir on EHVā€5 viral load measured by qPCR in blood, nasal secretions (NS) and BALF in horses with EMPF on six horses diagnosed with EMPF.

  • Radiculopathy associated with forelimb lameness in horsesmembers
  • Biological variations of routine blood parameters in horsesmembers
  • Prognosis for horses with deep digital flexor tendon injury after penetrating woundmembers
  • Possible maternal effect for the pace trait of horsesmembers
  • Flecainide on induced atrial fibrillation in horsesmembers
  • Sonographic technique to identify manica flexoria tears in horsesmembers
  • Novel prototype dynamic laryngoplasty system on arytenoid abductionmembers
  • Lipid peroxidation biomarkers in equine neuroaxonal dystrophymembers
  • Eosinophils of the horse: an updatemembers
  • Presumed Neuroglycopenia following Severe Hypoglycemia in Horsesmembers
  • E321G MYH1 mutation and nonexertional rhabdomyolysis in Quarter Horsesmembers
  • Novel therapeutic approach for mares with suspected uterine tubal blockagemembers


  • [ Home ] [ About ] [ Contact / Request ] [ Privacy Policy ]

    Copyright © 2001-2018 VetContact GmbH
    All rights reserved